FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005431320> ?p ?o ?g. }

• W2005431320 endingPage "158" @default.
• W2005431320 startingPage "142" @default.
• W2005431320 abstract "Salivary gland carcinomas constitute a heterogeneous group of tumors, with over 20 histological subtypes of various prognoses. The mainstay of treatment is surgery, with radiotherapy advocated for unresectable disease or postoperatively in case of poor prognostic factors such as high grade, locally advanced and/or incompletely resected tumors. Concurrent chemotherapy is sometimes advocated in routine practice based on criteria extrapolated from squamous cell carcinomas of the head and neck, on radioresistance of salivary gland tumors and on results obtained in the metastatic setting. The aim of this review was to identify situations where chemotherapy is advocated. A search of literature was performed with the following key words: parotid, salivary gland, neoplasm, cancer, malignant tumor, chemoradiation, chemotherapy, radiotherapy and treatment. Case report and studies published before 2000 were not included. Platinum-based regimens were the most frequent. Other regimens were reported and seemed dependent on histology. The level of evidence for the concurrent delivery of chemotherapy with radiation therapy is supported by a low level of evidence. Prescribing chemotherapy mostly relies on poor prognostic factors similar to those used to indicate high dose radiotherapy. Protocols vary with histology. The rationale for adding chemotherapy to radiotherapy remains to be demonstrated prospectively. Although the type of systemic treatments used may be adapted on histology, the strongest rationale remains in favor of cisplatin." @default.
• W2005431320 created "2016-06-24" @default.
• W2005431320 creator A5001251992 @default.
• W2005431320 creator A5001353169 @default.
• W2005431320 creator A5023334743 @default.
• W2005431320 creator A5025807582 @default.
• W2005431320 creator A5028392553 @default.
• W2005431320 creator A5051463725 @default.
• W2005431320 creator A5052676428 @default.
• W2005431320 creator A5060029300 @default.
• W2005431320 creator A5060300187 @default.
• W2005431320 creator A5066266071 @default.
• W2005431320 creator A5079323740 @default.
• W2005431320 date "2014-08-01" @default.
• W2005431320 modified "2023-10-18" @default.
• W2005431320 title "A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network)" @default.
• W2005431320 cites W1582081261 @default.
• W2005431320 cites W1596423757 @default.
• W2005431320 cites W1963709097 @default.
• W2005431320 cites W1964455746 @default.
• W2005431320 cites W1965751851 @default.
• W2005431320 cites W1966675362 @default.
• W2005431320 cites W1967537163 @default.
• W2005431320 cites W1967921988 @default.
• W2005431320 cites W1974084001 @default.
• W2005431320 cites W1975800817 @default.
• W2005431320 cites W1987570173 @default.
• W2005431320 cites W1987994934 @default.
• W2005431320 cites W1988540705 @default.
• W2005431320 cites W1994890851 @default.
• W2005431320 cites W2000076327 @default.
• W2005431320 cites W2003040753 @default.
• W2005431320 cites W2005170380 @default.
• W2005431320 cites W2005621869 @default.
• W2005431320 cites W2005760008 @default.
• W2005431320 cites W2006271634 @default.
• W2005431320 cites W2007918090 @default.
• W2005431320 cites W2008016739 @default.
• W2005431320 cites W2008200288 @default.
• W2005431320 cites W2020052631 @default.
• W2005431320 cites W2022752041 @default.
• W2005431320 cites W2024456568 @default.
• W2005431320 cites W2026601125 @default.
• W2005431320 cites W2028678862 @default.
• W2005431320 cites W2029981809 @default.
• W2005431320 cites W2034341768 @default.
• W2005431320 cites W2036026634 @default.
• W2005431320 cites W2039480782 @default.
• W2005431320 cites W2043073129 @default.
• W2005431320 cites W2045274228 @default.
• W2005431320 cites W2048007487 @default.
• W2005431320 cites W2051574869 @default.
• W2005431320 cites W2051782985 @default.
• W2005431320 cites W2064326633 @default.
• W2005431320 cites W2070165953 @default.
• W2005431320 cites W2072138182 @default.
• W2005431320 cites W2072546233 @default.
• W2005431320 cites W2079346637 @default.
• W2005431320 cites W2086678509 @default.
• W2005431320 cites W2089316632 @default.
• W2005431320 cites W2093822070 @default.
• W2005431320 cites W2098523473 @default.
• W2005431320 cites W2101303012 @default.
• W2005431320 cites W2107283511 @default.
• W2005431320 cites W2108441775 @default.
• W2005431320 cites W2114122068 @default.
• W2005431320 cites W2118495823 @default.
• W2005431320 cites W2119891352 @default.
• W2005431320 cites W2121965402 @default.
• W2005431320 cites W2127922647 @default.
• W2005431320 cites W2128512366 @default.
• W2005431320 cites W2132156261 @default.
• W2005431320 cites W2138175422 @default.
• W2005431320 cites W2139337472 @default.
• W2005431320 cites W2140910522 @default.
• W2005431320 cites W2141615233 @default.
• W2005431320 cites W2143731103 @default.
• W2005431320 cites W2145665617 @default.
• W2005431320 cites W2146234796 @default.
• W2005431320 cites W2154319985 @default.
• W2005431320 cites W2155364345 @default.
• W2005431320 cites W2158869829 @default.
• W2005431320 cites W2162550324 @default.
• W2005431320 cites W21984198 @default.
• W2005431320 cites W2315403746 @default.
• W2005431320 cites W2334527906 @default.
• W2005431320 cites W2405382406 @default.
• W2005431320 cites W73338665 @default.
• W2005431320 doi "https://doi.org/10.1016/j.critrevonc.2014.02.002" @default.
• W2005431320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24636481" @default.
• W2005431320 hasPublicationYear "2014" @default.
• W2005431320 type Work @default.
• W2005431320 sameAs 2005431320 @default.
• W2005431320 citedByCount "59" @default.
• W2005431320 countsByYear W20054313202014 @default.
• W2005431320 countsByYear W20054313202015 @default.
• W2005431320 countsByYear W20054313202016 @default.
• W2005431320 countsByYear W20054313202017 @default.

• next